| Dr Neal Khurana, MD | |
|
705 N Sioux Point Rd Ste 100, Dakota Dunes, SD 57049-5091 | |
| (605) 217-5500 | |
| (605) 217-5515 |
| Full Name | Dr Neal Khurana |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 14 Years |
| Location | 705 N Sioux Point Rd Ste 100, Dakota Dunes, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184919490 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Siouxland | Sioux city, IA | Hospital |
| Burgess Health Center | Onawa, IA | Hospital |
| St Lukes Regional Medical Center | Sioux city, IA | Hospital |
| Horn Memorial Hospital | Ida grove, IA | Hospital |
| Orange City Area Health System | Orange city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vascular And Interventional Radiology Of Siouxland | 7113330663 | 12 |
| Sage Medical Prof Llc | 4385992619 | 6 |
| Vascular And Interventional Radiology Of Siouxland | 7113330663 | 12 |
| Vascular And Interventional Radiology Of Siouxland | 7113330663 | 12 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.
Researchers at UT Southwestern Medical Center at Dallas have identified a protein that transports the essential nutrient boron into cells, where it is important for cell growth and bone development. The findings are in the Nov. 5 edition of the journal Molecular Cell and are online.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of infectious diseases, announced it has successfully filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) to test SQ109 in patients suffering from H. pylori-related duodenal ulcers, and can now begin Phase 2 studies.
› Verified 7 days ago
| Entity Name | Vascular & Interventional Radiology Of Siouxland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225636129 PECOS PAC ID: 7113330663 Enrollment ID: O20201230002359 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.
Researchers at UT Southwestern Medical Center at Dallas have identified a protein that transports the essential nutrient boron into cells, where it is important for cell growth and bone development. The findings are in the Nov. 5 edition of the journal Molecular Cell and are online.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of infectious diseases, announced it has successfully filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) to test SQ109 in patients suffering from H. pylori-related duodenal ulcers, and can now begin Phase 2 studies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Neal Khurana, MD 705 N Sioux Point Rd Ste 100, Dakota Dunes, SD 57049-5091 Ph: (605) 217-5500 | Dr Neal Khurana, MD 705 N Sioux Point Rd Ste 100, Dakota Dunes, SD 57049-5091 Ph: (605) 217-5500 |
News Archive
A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.
Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.
Researchers at UT Southwestern Medical Center at Dallas have identified a protein that transports the essential nutrient boron into cells, where it is important for cell growth and bone development. The findings are in the Nov. 5 edition of the journal Molecular Cell and are online.
Thirty percent of patients surveyed experienced an infection as a result of chemotherapy, 45 percent of which were associated with neutropenia or febrile neutropenia according to findings from a pan-European patient and nurse survey presented today at the 7th Annual European Oncology Nursing Society Spring Convention.
Sequella, Inc., a clinical-stage company focused on commercializing novel drugs for treatment of infectious diseases, announced it has successfully filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) to test SQ109 in patients suffering from H. pylori-related duodenal ulcers, and can now begin Phase 2 studies.
› Verified 7 days ago
Dr. Peter G Canaday, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 706 E Saint Andrews Cir, Peter Canaday Md Pc, Dakota Dunes, SD 57049 Phone: 720-951-3502 | |
Fahima A Qalbani, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 612 N Sioux Point Rd, Ste 500, Dakota Dunes, SD 57049 Phone: 605-232-6200 Fax: 605-235-0004 | |
Dr. Jacinto Camarena Iii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 345 W Steamboat Dr Ste 601, Dakota Dunes, SD 57049 Phone: 605-217-5617 Fax: 605-217-5533 |